| |
| Physical Characters and Index |
Product Name:Setipiprant
Other name:KYTH-105, ACT-129968
CAS:866460-33-5
Molecular Formula:C24H19FN2O3
Molecular Weight:402.42
Purity:99%
Appearance:White or off-white crystalline powder. |
| |
| Use and description |
| Setipiprant (INN; developmental code names ACT-129968, KYTH-105) is an investigational drug developed for the treatment of asthma and scalp hair loss. It was originally developed by Actelion and acts as a selective, orally available antagonist of the prostaglandin D2 receptor 2 (DP2). The drug is being developed as a novel treatment for male pattern baldness by Allergan. |
|
